Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@BiotechTV Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1655096847793377284.png) @BiotechTV BiotechTV

BiotechTV posts on X about $imrx, derek, $urgn, $orka the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1655096847793377284/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1655096847793377284/c:line/m:interactions.svg)

- X Week XXXXXX -XX%
- X Month XXXXXX -XX%
- X Months XXXXXXX -XX%
- X Year XXXXXXXXX -XXXX%

### Mentions: XX [#](/creator/twitter::1655096847793377284/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1655096847793377284/c:line/m:posts_active.svg)

- X Week XX no change
- X Month XX -XX%
- X Months XXX +8.80%
- X Year XXX +56%

### Followers: XXXXX [#](/creator/twitter::1655096847793377284/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1655096847793377284/c:line/m:followers.svg)

- X Week XXXXX +0.23%
- X Month XXXXX +1.70%
- X Months XXXXX +19%
- X Year XXXXX +37%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1655096847793377284/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1655096847793377284/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1655096847793377284/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXX% [finance](/list/finance)  XXXX% [fashion brands](/list/fashion-brands)  XXXX% [exchanges](/list/exchanges)  XXXX% [cryptocurrencies](/list/cryptocurrencies)  XXXX%

**Social topic influence**
[$imrx](/topic/$imrx) #5, [derek](/topic/derek) 1.82%, [$urgn](/topic/$urgn) 1.82%, [$orka](/topic/$orka) 1.82%, [$avdl](/topic/$avdl) 1.82%, [$aard](/topic/$aard) 1.82%, [$smmt](/topic/$smmt) 1.82%, [$til](/topic/$til) 1.82%, [$cbio](/topic/$cbio) 1.82%, [asos](/topic/asos) XXXX%

**Top accounts mentioned or mentioned by**
[@arcellx](/creator/undefined) [@stifel](/creator/undefined) [@matteispaul](/creator/undefined) [@inductivebio](/creator/undefined) [@nucleaselab](/creator/undefined) [@dynotxs](/creator/undefined) [@discmedicines](/creator/undefined) [@beigeneglobal](/creator/undefined) [@mizuho](/creator/undefined) [@salimqsyed](/creator/undefined) [@enterobiotix](/creator/undefined) [@mizuhoamericas](/creator/undefined) [@kymeratxs](/creator/undefined) [@nellomainolfi](/creator/undefined) [@seaporttx](/creator/undefined) [@daphnezohar](/creator/undefined) [@trevithera](/creator/undefined) [@pharvaris](/creator/undefined) [@vervetx](/creator/undefined) [@skathire](/creator/undefined)

**Top assets mentioned**
[Oruka Therapeutics, Inc. Common Stock (ORKA)](/topic/$orka) [Summit Therapeutics Inc. Common Stock (SMMT)](/topic/$smmt) [Sanofi (SNY)](/topic/sanofi) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Soleno Therapeutics, Inc. Common Stock (SLNO)](/topic/$slno) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Crinetics Pharmaceuticals, Inc. (CRNX)](/topic/$crnx) [Xenon Pharmaceuticals Inc (XENE)](/topic/$xene) [Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [Vertex Protocol (VRTX)](/topic/$vrtx) [Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/dyne-therapeutics)
### Top Social Posts [#](/creator/twitter::1655096847793377284/posts)
---
Top posts by engagements in the last XX hours

": @benchlings Head of Product - Applications Derek Halliday describes how technology is changing the Development side of R&D and how Benchling has helped Merck modernize its bioanalytical systems in this regard. #sponsored"  
[X Link](https://x.com/BiotechTV/status/1978206872931803549) [@BiotechTV](/creator/x/BiotechTV) 2025-10-14T21:10Z 9438 followers, 1555 engagements


": Closing out BiotechTV's coverage of the @HCWCO Global Investor Conference with Managing Director and Senior Analyst Ram Selvaraju. He discusses the conference and names he covers. $URGN $ORKA $AVDL $AARD $SMMT $TIL $CBIO Full video:"  
[X Link](https://x.com/BiotechTV/status/1965555986376393063) [@BiotechTV](/creator/x/BiotechTV) 2025-09-09T23:20Z 9440 followers, 2091 engagements


": Souffl Therapeutics exited stealth today with the goal of developing nucleic acid therapies like siRNAs & ASOs delivered to any cell in the body by targeting internalizing receptors. CEO @VCAmir talks the science. Full video:"  
[X Link](https://x.com/BiotechTV/status/1975546911659860198) [@BiotechTV](/creator/x/BiotechTV) 2025-10-07T13:01Z 9440 followers, 4217 engagements


": BiotechTV will be back in NYC broadcasting from the iconic @NYSE tomorrow afternoon. Please tune in. $NUVB $IMRX"  
[X Link](https://x.com/BiotechTV/status/1975642478750367956) [@BiotechTV](/creator/x/BiotechTV) 2025-10-07T19:20Z 9442 followers, 12.2K engagements


": Oxford's @organ_ox became one of the UK's biggest news stories when it was announced it would be acquired by Japan's Terumo for approximately $XXX billion - here's the revolutionary technology behind it. Full video:"  
[X Link](https://x.com/BiotechTV/status/1976644818320392290) [@BiotechTV](/creator/x/BiotechTV) 2025-10-10T13:43Z 9439 followers, 1194 engagements


": Kate Haviland discusses the $9B+ acquisition of Blueprint by Sanofi being chair of Fulcrum her thoughts on M&A and what is interesting in biotech today. Full video:"  
[X Link](https://x.com/BiotechTV/status/1978242737057956218) [@BiotechTV](/creator/x/BiotechTV) 2025-10-14T23:33Z 9439 followers, 1666 engagements


": @ionispharma's CEO Brett Monia discusses the recent trial success of olezarsen in severe hypertriglyceridemia the approval of Dawnzera in HAE and more. $IONS Full video:"  
[X Link](https://x.com/BiotechTV/status/1965137041282531580) [@BiotechTV](/creator/x/BiotechTV) 2025-09-08T19:35Z 9442 followers, 4774 engagements


": @AstriaTx licensed its HAE treatment Navenibart to Kaken Pharmaceutical for the Japanese market. It is a kallikrein inhibitor that is in phase X and is dosed up to every six months. $ATXS Full video:"  
[X Link](https://x.com/BiotechTV/status/1953537900907294759) [@BiotechTV](/creator/x/BiotechTV) 2025-08-07T19:25Z 9442 followers, 1835 engagements


": R.W. Baird Managing Director & Senior Biotech Analyst @BrianSkorney discusses numerous battleground companies in biotech. $SLNO $SRPT $LXEO $ENTA $CRNX $VRTX $XENE $BHVN Full video:"  
[X Link](https://x.com/BiotechTV/status/1976052122505576769) [@BiotechTV](/creator/x/BiotechTV) 2025-10-08T22:28Z 9438 followers, 38.5K engagements


": @Dyne_tx's CSO Ron Batra describes the company's FORCE platform and previews big trial readouts scheduled in DMD and DM1 over the next year. $DYN Full video:"  
[X Link](https://x.com/BiotechTV/status/1978133252591280386) [@BiotechTV](/creator/x/BiotechTV) 2025-10-14T16:18Z 9438 followers, 1377 engagements


": @Immuneering's CEO walks us through the company's MEK data in pancreatic cancer and explains the science behind 'deep cyclic inhibition'. $IMRX Full video:"  
[X Link](https://x.com/BiotechTV/status/1976140728234393745) [@BiotechTV](/creator/x/BiotechTV) 2025-10-09T04:20Z 9438 followers, 4032 engagements


": This week @Regeneron published data in @NEJM showing that its gene therapy improved hearing and speech perception in XX of XX children with a genetic form of hearing loss. @chloeckirk breaks it down. Link to research:"  
[X Link](https://x.com/BiotechTV/status/1979295979456118902) [@BiotechTV](/creator/x/BiotechTV) 2025-10-17T21:18Z 9438 followers, 4091 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BiotechTV Avatar @BiotechTV BiotechTV

BiotechTV posts on X about $imrx, derek, $urgn, $orka the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Week XXXXXX -XX%
  • X Month XXXXXX -XX%
  • X Months XXXXXXX -XX%
  • X Year XXXXXXXXX -XXXX%

Mentions: XX #

Mentions Line Chart

  • X Week XX no change
  • X Month XX -XX%
  • X Months XXX +8.80%
  • X Year XXX +56%

Followers: XXXXX #

Followers Line Chart

  • X Week XXXXX +0.23%
  • X Month XXXXX +1.70%
  • X Months XXXXX +19%
  • X Year XXXXX +37%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence stocks XXXX% finance XXXX% fashion brands XXXX% exchanges XXXX% cryptocurrencies XXXX%

Social topic influence $imrx #5, derek 1.82%, $urgn 1.82%, $orka 1.82%, $avdl 1.82%, $aard 1.82%, $smmt 1.82%, $til 1.82%, $cbio 1.82%, asos XXXX%

Top accounts mentioned or mentioned by @arcellx @stifel @matteispaul @inductivebio @nucleaselab @dynotxs @discmedicines @beigeneglobal @mizuho @salimqsyed @enterobiotix @mizuhoamericas @kymeratxs @nellomainolfi @seaporttx @daphnezohar @trevithera @pharvaris @vervetx @skathire

Top assets mentioned Oruka Therapeutics, Inc. Common Stock (ORKA) Summit Therapeutics Inc. Common Stock (SMMT) Sanofi (SNY) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Soleno Therapeutics, Inc. Common Stock (SLNO) Sarepta Therapeutics, Inc. (SRPT) Crinetics Pharmaceuticals, Inc. (CRNX) Xenon Pharmaceuticals Inc (XENE) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Vertex Protocol (VRTX) Dyne Therapeutics, Inc. Common Stock (DYN)

Top Social Posts #


Top posts by engagements in the last XX hours

": @benchlings Head of Product - Applications Derek Halliday describes how technology is changing the Development side of R&D and how Benchling has helped Merck modernize its bioanalytical systems in this regard. #sponsored"
X Link @BiotechTV 2025-10-14T21:10Z 9438 followers, 1555 engagements

": Closing out BiotechTV's coverage of the @HCWCO Global Investor Conference with Managing Director and Senior Analyst Ram Selvaraju. He discusses the conference and names he covers. $URGN $ORKA $AVDL $AARD $SMMT $TIL $CBIO Full video:"
X Link @BiotechTV 2025-09-09T23:20Z 9440 followers, 2091 engagements

": Souffl Therapeutics exited stealth today with the goal of developing nucleic acid therapies like siRNAs & ASOs delivered to any cell in the body by targeting internalizing receptors. CEO @VCAmir talks the science. Full video:"
X Link @BiotechTV 2025-10-07T13:01Z 9440 followers, 4217 engagements

": BiotechTV will be back in NYC broadcasting from the iconic @NYSE tomorrow afternoon. Please tune in. $NUVB $IMRX"
X Link @BiotechTV 2025-10-07T19:20Z 9442 followers, 12.2K engagements

": Oxford's @organ_ox became one of the UK's biggest news stories when it was announced it would be acquired by Japan's Terumo for approximately $XXX billion - here's the revolutionary technology behind it. Full video:"
X Link @BiotechTV 2025-10-10T13:43Z 9439 followers, 1194 engagements

": Kate Haviland discusses the $9B+ acquisition of Blueprint by Sanofi being chair of Fulcrum her thoughts on M&A and what is interesting in biotech today. Full video:"
X Link @BiotechTV 2025-10-14T23:33Z 9439 followers, 1666 engagements

": @ionispharma's CEO Brett Monia discusses the recent trial success of olezarsen in severe hypertriglyceridemia the approval of Dawnzera in HAE and more. $IONS Full video:"
X Link @BiotechTV 2025-09-08T19:35Z 9442 followers, 4774 engagements

": @AstriaTx licensed its HAE treatment Navenibart to Kaken Pharmaceutical for the Japanese market. It is a kallikrein inhibitor that is in phase X and is dosed up to every six months. $ATXS Full video:"
X Link @BiotechTV 2025-08-07T19:25Z 9442 followers, 1835 engagements

": R.W. Baird Managing Director & Senior Biotech Analyst @BrianSkorney discusses numerous battleground companies in biotech. $SLNO $SRPT $LXEO $ENTA $CRNX $VRTX $XENE $BHVN Full video:"
X Link @BiotechTV 2025-10-08T22:28Z 9438 followers, 38.5K engagements

": @Dyne_tx's CSO Ron Batra describes the company's FORCE platform and previews big trial readouts scheduled in DMD and DM1 over the next year. $DYN Full video:"
X Link @BiotechTV 2025-10-14T16:18Z 9438 followers, 1377 engagements

": @Immuneering's CEO walks us through the company's MEK data in pancreatic cancer and explains the science behind 'deep cyclic inhibition'. $IMRX Full video:"
X Link @BiotechTV 2025-10-09T04:20Z 9438 followers, 4032 engagements

": This week @Regeneron published data in @NEJM showing that its gene therapy improved hearing and speech perception in XX of XX children with a genetic form of hearing loss. @chloeckirk breaks it down. Link to research:"
X Link @BiotechTV 2025-10-17T21:18Z 9438 followers, 4091 engagements

@BiotechTV
/creator/twitter::BiotechTV